Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03420430
Title Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Genelux Corporation

hematologic cancer

Advanced Solid Tumor



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.